264 related articles for article (PubMed ID: 6359424)
1. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
Larrey D; Branch RA
Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
[No Abstract] [Full Text] [Related]
2. [Dose adaptation of drugs for liver patients using a simple risk classification].
Zysset T; Bircher J
Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
[No Abstract] [Full Text] [Related]
3. [Liver and metabolism of drugs].
Darnis F
Cah Med; 1974 Oct; 15(10):637-43. PubMed ID: 4455367
[No Abstract] [Full Text] [Related]
4. [Role of liver in the metabolism of drugs (literature review)].
Mansurova ID
Sov Med; 1973 Nov; 36(11):83-7. PubMed ID: 4595463
[No Abstract] [Full Text] [Related]
5. Hepatic circulation and drug disposition in cirrhosis.
Shand DG
Gastroenterology; 1979 Jul; 77(1):185-6. PubMed ID: 447017
[No Abstract] [Full Text] [Related]
6. Non-invasive methods for the assessment of hepatic drug disposition.
Bircher J
Int J Clin Pharmacol Res; 1983; 3(6):415-9. PubMed ID: 6432711
[TBL] [Abstract][Full Text] [Related]
7. Drug disposition in liver disease.
Fruncillo RJ
Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
[No Abstract] [Full Text] [Related]
8. [Effects of liver disease on drug pharmacokinetics].
Su CY
Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457
[No Abstract] [Full Text] [Related]
9. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
Perrier D; Gibaldi M
J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
[No Abstract] [Full Text] [Related]
10. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
Kearns GL
Ann Pharmacother; 1993 Jan; 27(1):74-9. PubMed ID: 8431626
[TBL] [Abstract][Full Text] [Related]
11. Effects of liver congestion on hepatic drug metabolism in the rat.
Knodell RG; Farleigh RM; Steele NM; Bond JH
J Pharmacol Exp Ther; 1982 Apr; 221(1):52-7. PubMed ID: 7062291
[TBL] [Abstract][Full Text] [Related]
12. Drug administration in hepatic disease.
Williams RL
N Engl J Med; 1983 Dec; 309(26):1616-22. PubMed ID: 6358891
[No Abstract] [Full Text] [Related]
13. [Prescription of drugs in liver diseases].
Held H
Internist (Berl); 1980 Dec; 21(12):724-34. PubMed ID: 7009474
[No Abstract] [Full Text] [Related]
14. Drugs and the ageing liver.
James OF
J Hepatol; 1985; 1(4):431-5. PubMed ID: 3902953
[No Abstract] [Full Text] [Related]
15. [How to evaluate hepatic function: pharmacokinetic approach].
Malè PJ
Rev Med Suisse Romande; 1985 Apr; 105(4):313-6. PubMed ID: 4012141
[No Abstract] [Full Text] [Related]
16. Assessment of liver function: the current situation.
Van Thiel DH; Hassanein T
J Okla State Med Assoc; 1995 Jan; 88(1):11-6. PubMed ID: 7897548
[TBL] [Abstract][Full Text] [Related]
17. The influence of host factors on drug response. VI. Hepatocellular diseases.
Vesell ES
Ration Drug Ther; 1981 Aug; 15(8):1-8. PubMed ID: 7347855
[No Abstract] [Full Text] [Related]
18. Clearance approaches in pharmacology.
Wilkinson GR
Pharmacol Rev; 1987 Mar; 39(1):1-47. PubMed ID: 3554275
[No Abstract] [Full Text] [Related]
19. [Effect of various physiological and pathological conditions on the bioavailability of drugs].
Danysz A; Wierzba K
Pol Tyg Lek; 1979 Jan; 34(4):141-3. PubMed ID: 432125
[No Abstract] [Full Text] [Related]
20. Hepatic clearance measurements and pharmacokinetics.
Keiding S; Andreasen PB
Pharmacology; 1979; 19(3):105-10. PubMed ID: 392549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
